The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2020

Filed:

Apr. 11, 2014
Applicants:

Vanderbilt University, Nashville, TN (US);

The United States As Represented BY the Department of Veterans Affairs, Washington, DC (US);

Inventors:

Craig Duvall, Nashville, TN (US);

Brian Connor Evans, Bartlett, TN (US);

Colleen Brophy, Nashville, TN (US);

Kyle Hocking, Alpharetta, GA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7105 (2006.01); A61K 47/32 (2006.01); A61K 9/00 (2006.01); A61K 38/55 (2006.01); A61K 47/69 (2017.01); A61K 47/58 (2017.01); A61K 31/711 (2006.01); A61K 38/00 (2006.01); A61L 27/26 (2006.01); A61L 27/54 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7105 (2013.01); A61K 9/0019 (2013.01); A61K 31/711 (2013.01); A61K 38/005 (2013.01); A61K 38/55 (2013.01); A61K 47/32 (2013.01); A61K 47/58 (2017.08); A61K 47/6927 (2017.08); A61L 27/26 (2013.01); A61L 27/54 (2013.01); A61L 2300/252 (2013.01);
Abstract

The present disclosure relates to compounds comprising (i) an active agent, wherein the active agent includes a charge at a predetermined pH, (ii) a polymer, wherein the polymer includes an opposite charge than the active agent at the predetermined pH; and (iii) a polyplex comprising the peptide and the polymer electrostatically bond together at the predetermined pH. In some embodiments, the active agent is a peptide, such as a peptide comprising MAPKAP kinase II inhibitory peptide, and in some embodiments the peptide includes a cell-penetrating peptide. In further embodiments, the disclosure provides methods for treating a disease or condition by administering a composition according to the present disclosure to a subject in need thereof.


Find Patent Forward Citations

Loading…